Several metabolic pathways are involved in the progression of metabolic abnormalities during the development of obesity, leading to changes in adipose tissue inflammation, insulin resistance and adipogenesis [3]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.